SAM
TPST icon

Sectoral Asset Management’s Tempest Therapeutics TPST Stock Holding History

Sectoral Asset Management’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,876
Closed -$279K – 129
2023
Q2 		$279K Buy
+16,876
New +$425K 0.05% 113

Other funds holding TPST

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sectoral Asset Management's TPST Position: Q3 2023 in Review

Sectoral Asset Management sold out of Tempest Therapeutics (TPST) in Q3 2023, closing a stake of 16,876 shares — an estimated $279K sold.

Sectoral Asset Management first reported a position in TPST in Q2 2023 and held it in 1 quarter. The position peaked at $279K in Q2 2023. 23 funds tracked by Wall St. Rank hold TPST as of Q3 2023.

  • Sectoral Asset Management reported no remaining Tempest Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Sectoral Asset Management sold 16,876 Tempest Therapeutics shares in Q3 2023, an estimated $279K.
  • Sectoral Asset Management first reported a position in Tempest Therapeutics in Q2 2023 and held it in 1 quarter.
  • Sectoral Asset Management's Tempest Therapeutics position peaked at $279K in Q2 2023.
  • 23 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2023.

Based on Sectoral Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.